Elicera Therapeutics: Promising first data from CARMA study - Redeye
Bildkälla: Stockfoto

Elicera Therapeutics: Promising first data from CARMA study - Redeye

Redeye gives an initial take on the first clinical results from the CARMA study with ELC-301.

Redeye gives an initial take on the first clinical results from the CARMA study with ELC-301.
Börsvärldens nyhetsbrev
ANNONSER